167 related articles for article (PubMed ID: 1348434)
21. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
23. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
24. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
[TBL] [Abstract][Full Text] [Related]
25. Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Link H; Arseniev L; Bähre O; Berenson RJ; Battmer K; Kadar JG; Jacobs R; Casper J; Kühl J; Schubert J; Diedrich H; Poliwoda H
Blood; 1995 Oct; 86(7):2500-8. PubMed ID: 7545459
[TBL] [Abstract][Full Text] [Related]
26. Modulation of responsiveness of chronic myelogenous leukemia granulocyte-macrophage colony-forming cells to growth regulation following in vivo treatment with recombinant gamma-interferon.
Pelus LM; Vadhan-Raj S
Am J Hematol; 1988 May; 28(1):21-6. PubMed ID: 3130750
[TBL] [Abstract][Full Text] [Related]
27. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
[TBL] [Abstract][Full Text] [Related]
28. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
Freedman MH; Hitzler JK; Bunin N; Grunberger T; Squire J
Stem Cells; 1996 Nov; 14(6):690-701. PubMed ID: 8948026
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of one case of adult chronic myelogenous leukemia by two units of unrelated umbilical cord blood transplantation].
He JS; Huang H; Cai Z; Li L; Ye XJ; Zhang J; Hu XR; Jin AY; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):508-11. PubMed ID: 14575547
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
[TBL] [Abstract][Full Text] [Related]
31. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
33. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
Sanz GF; Saavedra S; Jiménez C; Senent L; Cervera J; Planelles D; Bolufer P; Larrea L; Martín G; Martínez J; Jarque I; Moscardó F; Plumé G; Andreu R; de la Rubia J; Barragán E; Solves P; Soler MA; Sanz MA
Bone Marrow Transplant; 2001 Apr; 27(7):693-701. PubMed ID: 11360108
[TBL] [Abstract][Full Text] [Related]
34. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.
Broxmeyer HE; Douglas GW; Hangoc G; Cooper S; Bard J; English D; Arny M; Thomas L; Boyse EA
Proc Natl Acad Sci U S A; 1989 May; 86(10):3828-32. PubMed ID: 2566997
[TBL] [Abstract][Full Text] [Related]
35. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
[TBL] [Abstract][Full Text] [Related]
36. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia.
Sawai N; Koike K; Higuchi T; Ogami K; Oda M
Blood; 1998 Jun; 91(11):4065-73. PubMed ID: 9596651
[TBL] [Abstract][Full Text] [Related]
38. Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation.
Ma DD; Varga DE; Biggs JC
Leuk Res; 1987; 11(2):141-7. PubMed ID: 3546956
[TBL] [Abstract][Full Text] [Related]
39. Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone.
Voog E; Le QH; Philip I; Benetaib B; Michallet M; Fiere D; Thomas X
Ann Hematol; 2001 Oct; 80(10):584-91. PubMed ID: 11732869
[TBL] [Abstract][Full Text] [Related]
40. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood.
To LB; Shepperd KM; Haylock DN; Dyson PG; Charles P; Thorp DL; Dale BM; Dart GW; Roberts MM; Sage RE
Exp Hematol; 1990 Jun; 18(5):442-7. PubMed ID: 1970963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
